Kelly Chen

Kelly Chen

Auto-generated profile, based on publicly available information

Kelly Chen

Department of Neurology and Neurological Sciences, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
KCKelly Chen
Kelly Chen
NBNora Barnes-Horowitz
Nora Barnes-Horowitz
MTMichael Treanor
Michael Treanor
MSMichael Sun
Michael Sun
KYKatherine Young
Katherine Young
MCMichelle G. Craske
Michelle G. Craske
Anhedonia is a risk factor for suicide and poor treatment response in depressed individuals. Most evidence-based psychological therapies target symptoms of heightened negative affect (e.g., negative inferential style) instead of deficits in positive affect (e.g., attenuated reward response) and typically show little benefit for anhedonia. Viewing positive scenes through virtual reality (VR) has been shown to increase positive affect and holds great promise for addressing anhedonic symptoms. In this pilot study, six participants with clinically significant depression completed 13 sessions of exposure to positive scenes in a controlled VR environment. Significant decreases were found in self-reported anhedonia, depression, anxiety, and impairments in functioning from baseline to 1-month follow-up. Negative affect decreased over all 13 sessions, and positive affect increased over sessions 8–13. Results suggest that positive experiences in VR may be a novel avenue for the treatment of anhedonia in depressed individuals.

11 November 2024 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
LMLisa N. Miller
Lisa N. Miller
AWAshley E. Walters
Ashley E. Walters
JDJiyeon K. Denninger
Jiyeon K. Denninger
MHMeretta A. Hanson
Meretta A. Hanson
AMAlec H. Marshall
Alec H. Marshall
Elizabeth D. KirbyElizabeth D. Kirby
Elizabeth D. Kirby

26 July 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
KCKelly S. Chen
Kelly S. Chen
YDYogesh Dwivedi
Yogesh Dwivedi
RSRichard C. Shelton
Richard C. Shelton

1 January 2021 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
MTMeredith E. Thomley
Meredith E. Thomley
CGCole N. Gross
Cole N. Gross
APAna Preda-Naumescu
Ana Preda-Naumescu
KCKelly S. Chen
Kelly S. Chen
TSThomas Swain
Thomas Swain
JCJason Crosson
Jason Crosson
The purpose of this study was to assess outcomes in a real‐world nonclinical trial setting of antivascular endothelial growth factor (VEGF) injections alone vs. focal laser combined with anti‐VEGF injections in patients with branch retinal vein occlusion‐ (BRVO‐) related macular edema (ME). This study included 88 BRVO with ME patients who were treated over three years at both a tertiary referral center in the Birmingham metropolitan area and satellites in rural Alabama. One group received only anti‐VEGF injections ( n = 56); the other group received both anti‐VEGF injections and focal laser ( n = 32). The following outcome measures were evaluated: initial and final visual acuities (VA), initial central subfield thickness (CST) on OCT, number of injections, number of lasers, percentage of patients with a gain of 3 lines of VA, percentage of patients with VA better than or equal to 20/40, and percentage of patients with VA worse than or equal to 20/200. We found that there was no difference in initial VA ( p = 0.913) or CST ( p = 0.961) between the two groups. The injection only group required a median of 7 injections, while the combination group required a median of 4 injections, but this was not a statistically significant difference ( p = 0.117). There was no difference in final VA ( p = 0.414) or any of the other visual outcomes between the two groups. In conclusion, focal laser did not decrease the number of injections required or improve the VA in BRVO‐related ME. Although visual outcomes were similar in both groups, focal laser does not appear to be of additional benefit in BRVO‐related ME in the anti‐VEGF era.

3 April 2019 in Women's Reproductive Health
Verified
Journal Article
Closed access
KCKelly Chen
Kelly Chen
(2019). PCOS. Women's Reproductive Health: Vol. 6, No. 2, pp. 141-141.

29 April 2021 in Academic Psychiatry
Verified
Journal Article
Closed access
PDF file
KCKelly Chen
Kelly Chen